Examkin

Soru

Zorluk: Çok zorEnd-of-Life and Palliative Care

Evaluate the following complex end-of-life patient presentations and pair each with its most appropriate, symptom-specific intervention.

  • A 64-year-old man with multiple myeloma and acute oliguric renal failure develops diffuse allodynia and severe multifocal myoclonus while receiving continuous intravenous morphine.Discontinue the current opioid and rotate to a continuous infusion of fentanyl or methadone.
  • A 77-year-old woman with end-stage cor pulmonale is actively dying and exhibits profound air hunger. She is opioid-naive, lacks intravenous access, and her surrogate refuses new line placements.Administer concentrated liquid morphine sulfate via the sublingual or transmucosal route.
  • A 68-year-old man with metastatic gastric cancer is unresponsive in his final hours with distressing oropharyngeal secretions. He has a known history of closed-angle glaucoma.Administer subcutaneous glycopyrrolate to minimize systemic antimuscarinic side effects.
  • A 52-year-old woman with leptomeningeal carcinomatosis exhibits severe, hyperactive terminal delirium that remains completely refractory to escalating doses of intravenous haloperidol.Initiate proportional palliative sedation with a continuous intravenous infusion of midazolam.

Cevap

The correct pairings align the patient with opioid-induced neurotoxicity to fentanyl/methadone rotation, the patient with terminal dyspnea without IV access to sublingual morphine, the patient with terminal secretions and glaucoma to subcutaneous glycopyrrolate, and the patient with refractory terminal delirium to a continuous midazolam infusion.
Each vignette describes a highly specific, complex palliative care scenario requiring a tailored intervention. The correct matches prioritize patient safety, route availability, and precise pharmacological appropriateness in the setting of terminal illness and organ dysfunction.

Adım Adım Çözüm

1
Analyze the underlying etiology of the refractory symptom in the context of the patient's comorbidities.
Identified critical factors: acute renal failure causing morphine metabolite accumulation, lack of IV access in severe dyspnea, closed-angle glaucoma complicating anticholinergic use, and haloperidol failure in terminal delirium.
Comorbidities and prior treatment failures strictly dictate the next pharmacological step in advanced palliative care.
2
Identify the pharmacological properties and limitations of available palliative interventions.
Determined that morphine produces neurotoxic metabolites in renal failure, scopolamine crosses the blood-brain barrier and exacerbates glaucoma, and haloperidol has a ceiling effect for profound terminal agitation.
Matching the correct drug requires understanding its pharmacokinetics, route availability, and contraindications.
3
Select the targeted palliative intervention that bypasses the identified limitation while adhering to ethical end-of-life care principles.
Selected fentanyl for renal safety, sublingual morphine for non-invasive rapid absorption, glycopyrrolate for its inability to cross the blood-brain barrier, and midazolam for proportional palliative sedation.
Ensures evidence-based, safe, and effective symptom relief in the active dying phase.

Anahtar Kavram

Advanced symptom management in palliative care requires tailoring pharmacological interventions to patient-specific pharmacokinetic alterations (e.g., organ failure), strict contraindications (e.g., glaucoma), and the principle of proportional sedation for refractory distress.
Bu soruyu puanla

Konular

End-of-Life and Palliative Care

Bu konudan daha fazla soru